Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Baijin Life Science Holdings (OTCPK:MNNGF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Baijin Life Science Holdings's EV-to-EBIT for today is
Baijin Life Science Holdings's current Enterprise Value is $152.00 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $0.16 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Baijin Life Science Holdings's EV-to-EBITDA for today is:
Baijin Life Science Holdings's current Enterprise Value is $152.00 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $0.97 Mil.
Baijin Life Science Holdings's current Enterprise Value is $152.00 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Revenue for the trailing twelve months (TTM) ended in Sep. 2025 was $15.40 Mil.
Baijin Life Science Holdings's current Enterprise Value is $152.00 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.38 Mil.
Baijin Life Science Holdings's current Enterprise Value is $152.00 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Baijin Life Science Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings Enterprise Value Related Terms
Baijin Life Science Holdings Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings Enterprise Value Chart
For the Luxury Goods subindustry, Baijin Life Science Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Enterprise Value vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Enterprise Value falls into.
Baijin Life Science Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a Enterprise Value of $152.00 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Baijin Life Science Holdings and its competitors.
Is Baijin Life Science Holdings' Enterprise Value too high?
Baijin Life Science Holdings' current Enterprise Value is $152.00 Mil. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Enterprise Value compare to TPR?
Baijin Life Science Holdings' Enterprise Value of $152.00 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Retail - Cyclical company?
A good Enterprise Value depends on the Retail - Cyclical industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Enterprise Value is $152.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Enterprise Value of $152.00 Mil. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Enterprise Value is $152.00 Mil. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Enterprise Value is $152.00 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.
Key valuation signals for MNNGF:
Enterprise Value: $152.00 Mil
GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score
Get the complete analysis for MNNGF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
